# JAPAN PMDA STANDARDS — AION-BRAIN

**Document Classification:** Japanese Regulatory Framework Guidance  
**Effective Date:** November 2025  
**Version:** 3.0  
**Jurisdiction:** Japan  
**Regulatory Body:** Pharmaceuticals and Medical Devices Agency (PMDA)  
**License:** Apache License 2.0 with NOTICE file  
**Document Governance:** Legal Engine v2.2 (Hallucination-Hardened Safeguards) + Legal Engine 2 v1.5 (Systematic Compliance Analysis) + Regulatory Engine v2.5 (Multi-Jurisdictional Intelligence)

---

## Document Authority

### 10-Role Genius Council Validation

This Japanese regulatory framework document was developed through multi-perspective analysis:

| Role | Contribution |
|------|--------------|
| General Counsel | Japanese regulatory classification architecture |
| Chief Compliance Officer | PMDA compliance verification |
| Regulatory Affairs Director | PMD Act alignment validation |
| Privacy Officer | APPI integration review |
| Healthcare Compliance Specialist | Japanese clinical use restrictions |
| Risk Management Officer | Japanese regulatory risk assessment |
| International Legal Counsel | Japan-specific compliance |
| IP Counsel | Shonin approval implications |
| Ethics Counsel | Japanese medical ethics considerations |
| Terms & Governance Specialist | User obligation clarity |

### Engine Integration

- **Legal Engine v2.2:** Citation integrity, Japanese regulation validation
- **Legal Engine 2 v1.5:** Systematic Japanese compliance gap analysis
- **Regulatory Engine v2.5:** Japanese regulatory intelligence

---

## Executive Summary

**AION-BRAIN is NOT a PMDA-regulated medical device.** Users developing medical applications for Japan must independently ensure compliance with the Pharmaceutical and Medical Device Act (PMD Act).

| Status | Classification |
|--------|---------------|
| **PMDA Classification** | Not a medical device |
| **Marketing Authorization** | Not required |
| **JPAL Registration** | Not applicable |
| **Shonin (Approval)** | Not required |

---

## Japanese Regulatory Framework

### Pharmaceutical and Medical Device Act (PMD Act)

The PMD Act regulates medical devices in Japan, requiring marketing authorization for distribution.

### Classification System

| Class | Risk Level | Approval Type | Examples |
|-------|-----------|---------------|----------|
| **Class I** | Lowest | General medical devices | Stethoscopes, tongue depressors |
| **Class II** | Low-moderate | Controlled medical devices | X-ray systems, MRI |
| **Class III** | Moderate-high | Specially controlled devices | Dialysis equipment |
| **Class IV** | Highest | Specially controlled devices | Pacemakers, artificial organs |

### Software as Medical Device (SaMD)

PMDA has issued specific guidance on SaMD:

```
JAPAN SaMD CLASSIFICATION
═══════════════════════════════════════════════════════════════

Based on IMDRF SaMD framework adoption:

Category I (Non-serious) → Class I or II
Category II (Non-critical to serious) → Class II or III
Category III (Critical to serious) → Class III
Category IV (Critical to life-threatening) → Class IV

AI/ML-based SaMD:
├─► Requires Shonin (approval) for Class III-IV
├─► May require STED submission
└─► Post-market surveillance required

═══════════════════════════════════════════════════════════════
AION-BRAIN: NOT CLASSIFIED — Research framework only
```

---

## User Responsibilities for Japanese Market

### If You Develop Japanese Medical Software

| Obligation | Description |
|------------|-------------|
| **Classification** | Determine PMDA classification |
| **Marketing Authorization Holder (MAH)** | Establish or partner with MAH in Japan |
| **Clinical Trials** | May be required for higher classes |
| **STED Submission** | Summary Technical Documentation |
| **Post-Market Surveillance** | Required for all devices |

---

## Data Protection

### Act on the Protection of Personal Information (APPI)

| Requirement | Application |
|-------------|-------------|
| **Consent** | Consent for medical data collection |
| **Purpose Specification** | Clear purpose for data use |
| **Security Measures** | Technical and organizational safeguards |
| **International Transfers** | Restrictions on cross-border data flows |

---

## Contact Information

**PMDA:** https://www.pmda.go.jp/english/

---

## Disclaimer

This document provides informational guidance only and is NOT regulatory advice. Engage qualified Japanese regulatory affairs professionals for specific guidance.

---

**Document Version:** 2.0  
**Effective Date:** November 2025  
**License:** Apache License 2.0

*This document is part of the AION-BRAIN Legal Framework*
